Spencer's Retail [SPENCERS] vs Astal Laboratories [ASTALLTD] Detailed Stock Comparison
Spencer's Retail
NSE
Loading...
Astal Laboratories
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Spencer's Retail wins in 12 metrics, Astal Laboratories wins in 6 metrics, with 0 ties. Spencer's Retail appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Spencer's Retail | Astal Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2.09 | 10.84 | Spencer's Retail |
| Price-to-Book Ratio | -0.78 | 2.38 | Spencer's Retail |
| Debt-to-Equity Ratio | -2.38 | 36.86 | Spencer's Retail |
| PEG Ratio | -0.05 | 0.45 | Spencer's Retail |
| EV/EBITDA | -100.78 | 7.55 | Spencer's Retail |
| Profit Margin (TTM) | -14.20% | 12.33% | Astal Laboratories |
| Operating Margin (TTM) | -7.93% | 11.14% | Astal Laboratories |
| EBITDA Margin (TTM) | N/A | 11.14% | N/A |
| Return on Equity | 37.24% | 24.80% | Spencer's Retail |
| Return on Assets (TTM) | -18.81% | 14.09% | Astal Laboratories |
| Free Cash Flow (TTM) | $154.16M | $-182.92M | Spencer's Retail |
| 1-Year Return | -40.79% | -11.22% | Astal Laboratories |
| Price-to-Sales Ratio (TTM) | 0.28 | 1.24 | Spencer's Retail |
| Enterprise Value | $20.62B | $974.12M | Spencer's Retail |
| EV/Revenue Ratio | 1.11 | 1.29 | Spencer's Retail |
| Gross Profit Margin (TTM) | 20.83% | 15.24% | Spencer's Retail |
| Revenue per Share (TTM) | $207 | $77 | Spencer's Retail |
| Earnings per Share (Diluted) | $-29.39 | $8.06 | Astal Laboratories |
| Beta (Stock Volatility) | 0.09 | -0.84 | Astal Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Spencer's Retail vs Astal Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Spencer's Retail | 3.32% | 7.28% | 0.24% | -3.46% | -6.24% | -28.23% |
| Astal Laboratories | 5.68% | 9.05% | 13.43% | 7.87% | 11.05% | 17.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Spencer's Retail | -40.79% | -19.39% | -19.05% | -72.36% | -72.36% | -72.36% |
| Astal Laboratories | -11.22% | 104.90% | 104.90% | 104.90% | 104.90% | 104.90% |
News Based Sentiment: Spencer's Retail vs Astal Laboratories
Spencer's Retail
News based Sentiment: NEGATIVE
The month's developments paint a concerning picture for Spencer's Retail, with significant declines in sales and profitability, coupled with falling institutional investor participation. While there were some minor positive movements in share price, the overall trend is overwhelmingly negative, making this a high-risk investment.
Astal Laboratories
News based Sentiment: NEUTRAL
The month began with a stable trading day for Astal Laboratories, showing a slight increase in share price and consistent activity. While positive, the movement was not significant enough to indicate a major shift in the company's investment outlook, resulting in a neutral overall assessment.
Performance & Financial Health Analysis: Spencer's Retail vs Astal Laboratories
| Metric | SPENCERS | ASTALLTD |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.25B | ₹954.61M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 81,436 | 16,404 |
| 90 Day Avg. Volume | 100,984 | 16,065 |
| Last Close | ₹59.09 | ₹92.33 |
| 52 Week Range | ₹53.40 - ₹103.88 | ₹66.72 - ₹101.37 |
| % from 52W High | -43.12% | -8.92% |
| All-Time High | ₹225.00 (Jan 21, 2019) | ₹131.70 (Sep 09, 2024) |
| % from All-Time High | -73.74% | -29.89% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.24% | 0.91% |
| Quarterly Earnings Growth | -0.24% | 0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.12% |
| Operating Margin (TTM) | -0.08% | 0.11% |
| Return on Equity (TTM) | 0.37% | 0.25% |
| Debt to Equity (MRQ) | -2.38 | 36.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-73.40 | ₹36.75 |
| Cash per Share (MRQ) | ₹2.86 | ₹1.76 |
| Operating Cash Flow (TTM) | ₹-333,617,000 | ₹-116,989,000 |
| Levered Free Cash Flow (TTM) | ₹-2,463,623,000 | ₹89.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Spencer's Retail vs Astal Laboratories
| Metric | SPENCERS | ASTALLTD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2.09 | 10.84 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.05 | 0.45 |
| Price to Sales (TTM) | 0.28 | 1.24 |
| Price to Book (MRQ) | -0.78 | 2.38 |
| Market Capitalization | ||
| Market Capitalization | ₹5.25B | ₹954.61M |
| Enterprise Value | ₹20.62B | ₹974.12M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.11 | 1.29 |
| Enterprise to EBITDA | -100.78 | 7.55 |
| Risk & Other Metrics | ||
| Beta | 0.09 | -0.84 |
| Book Value per Share (MRQ) | ₹-73.40 | ₹36.75 |
Financial Statements Comparison: Spencer's Retail vs Astal Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SPENCERS | ASTALLTD |
|---|---|---|
| Revenue/Sales | ₹4.16B | ₹253.27M |
| Cost of Goods Sold | ₹3.29B | ₹214.66M |
| Gross Profit | ₹866.33M | ₹38.61M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-329.80M | ₹30.38M |
| EBITDA | ₹47.35M | ₹32.14M |
| Pre-Tax Income | ₹-616.68M | ₹27.93M |
| Income Tax | ₹-581,000 | ₹7.03M |
| Net Income (Profit) | ₹-616.10M | ₹20.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SPENCERS | ASTALLTD |
|---|---|---|
| Cash & Equivalents | ₹216.91M | ₹17.30M |
| Total Current Assets | ₹2.52B | ₹456.39M |
| Total Current Liabilities | ₹9.77B | ₹267.71M |
| Long-Term Debt | ₹9.59B | ₹4.56M |
| Total Shareholders Equity | ₹-6.62B | ₹359.95M |
| Retained Earnings | ₹-13.39B | ₹107.05M |
| Property, Plant & Equipment | ₹5.11B | ₹0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SPENCERS | ASTALLTD |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SPENCERS | ASTALLTD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 81,436 | 16,404 |
| Average Daily Volume (90 Day) | 100,984 | 16,065 |
| Shares Outstanding | 90.01M | 9.83M |
| Float Shares | 35.77M | 4.51M |
| % Held by Insiders | 0.62% | 0.51% |
| % Held by Institutions | 0.08% | 0.00% |
Dividend Analysis & Yield Comparison: Spencer's Retail vs Astal Laboratories
| Metric | SPENCERS | ASTALLTD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |